1. Thiabendazole is a widely used food preservative and anthelmintic d
rug for breeding animal species. In order to characterize precisely th
e cytochrome P450 isozyme(s) involved in its major route of metabolism
, a rapid and sensitive spectrofluorimetric method was developed for t
he simultaneous determination of thiabendazole and its main hepatic me
tabolite 5-hydroxythiabendazole. 2. The kinetics of thiabendazole 5-hy
droxylation were determined in microsomal preparations from control ra
bbits or animals previously treated with either P-naphthoflavone, isos
afrole, phenobarbital, rifampicin or clofibrate. These treatments led
to specific induction of CYP1A1, 1A2, 2B4, 3A6 and 4A1 respectively. 3
. By considering this panel of characterised microsomal preparations,
only those obtained from BNF-treated rabbits exhibited an increase in
thiabendazole 5-hydroxylase activity. Ethoxyresorufin O-deethylation i
n these microsomes was solely inhibited by thiabendazole. These argue
for a specific involvement of the CYP1A subfamily. 4. In the CYP1A sub
family, CYP1A2 appears to be responsible for basal 5-hydroxylation and
further unidentified metabolism of thiabendazole in control livers. H
owever, the major involvement of CYP1A1 is supported by the following
characteristics of 5-hydroxylation of thiabendazole: (1) the correlati
on with CYP1A1 expression and (2) the inhibition by ellipticine and no
t by furafylline, inhibitors of CYP1A1 and CYP1A2 respectively. 5. All
these data demonstrated that the rabbit cytochrome P4501A is predomin
antly involved in thiabendazole 5-hydroxylation which has been suspect
ed to be critical in terms of safety of the parent drug.